Download the Case Study

Delve into these case studies on ADC synthesis, development, and characterisation, where we reveal how:

  • Trastuzumab-based ADCs with multiple payload linkers demonstrated specific, targeted functional activity.
  • Flow cytometry and internalisation assays confirmed antigen targeting and cellular uptake.
  • Cytotoxicity assays revealed nanomolar IC50s only in HER2+ cell lines, confirming ADC efficacy and specific killing.